|
De Gea undergoing Man Utd medical
World Soccer David de Gea has arrived in England and is undergoing a medical ahead of his proposed move to Manchester United. The Spanish goalkeeper has been identified by Sir Alex Ferguson as the long-term successor to Edwin van der Sar at Old Trafford. … |
More:
De Gea undergoing Man Utd medical – World Soccer
25. June 2011
|
Intensive Therapy Yields Small Benefits in Type 2 Diabetes
Medscape Hopefully we will see an increasing difference between the 2 groups," he told Medscape Medical News at the conference. "One thing that strikes me about this study is how well the routine care group were treated," said Sue Kirkman, MD, … |
Read the original:
Intensive Therapy Yields Small Benefits in Type 2 Diabetes – Medscape
24. June 2011
|
ReCell 'skin' widens introduction
ModernMedicine Cambridge, England — Regenerative medicine firm Avita Medical, based here, introduced its ReCell Spray-On-Skin at a symposium held at the recent Cosmedica 2011 Congress for Aesthetic & Surgical Medicine held in Bochum, Germany, Medical News Today … |
See the article here:
ReCell ‘skin’ widens introduction – ModernMedicine
22. June 2011
|
Avita hosts ReCell symposium
ModernMedicine Cambridge, England — Regenerative medicine firm Avita Medical, based here, introduced its ReCell Spray-On-Skin at a symposium held at the recent Cosmedica 2011 Congress for Aesthetic & Surgical Medicine held in Bochum, Germany, Medical News Today … |
Originally posted here:
Avita hosts ReCell symposium – ModernMedicine
17. June 2011
|
Jury Out on Early Intervention for Psychosis
Medscape and it needs to be replicated urgently, ideally in a very large sample," Oliver Freudenreich, MD, who was not involved in the Cochrane review, told Medscape Medical News. He is director of the First Episode and Early Psychosis Program at Massachusetts … |
See more here:
Jury Out on Early Intervention for Psychosis – Medscape
17. June 2011
|
Prostate Cancer Kills Half Those Diagnosed in UK, But Not US
Medscape "I would rather have the potential — and I emphasize the potential — for overtreating than swing the other way and lose all of these patients to a disease that is curable," Dr. Thrasher explained in an interview with Medscape Medical News. … |
Visit link:
Prostate Cancer Kills Half Those Diagnosed in UK, But Not US – Medscape
16. June 2011
|
Acute Myeloid Leukemia Patients Overdosed With Cytarabine
Medscape The group recently published these findings in the New England Journal of Medicine (2011;364:1027-1036), as reported at the time by Medscape Medical News. Over the years, doses of cytarabine have ranged from 100 to 3000 mg/m 2 ; doses of 1000 mg/m 2 … |
Read this article:
Acute Myeloid Leukemia Patients Overdosed With Cytarabine – Medscape
15. June 2011
|
Blinatumomab Produced Complete Remission in ALL
Medscape We are testing it in the most aggressive B-cell malignancy we know," he told Medscape Medical News in an interview. The primary end point of the single-group, multicenter, exploratory phase 2 trial was the rate of CR or CR+. Secondary end points were … |
Go here to see the original:
Blinatumomab Produced Complete Remission in ALL – Medscape
14. June 2011
|
Navitoclax Activity in Heavily Pretreated CLL
Medscape "I think the most impressive aspects are that navitoclax is a well-tolerated drug, and it has activity despite these patients having adverse prognostic indicators," he told Medscape Medical News. Dr. Seymour presented the results here at the 16th … |
Read more here:
Navitoclax Activity in Heavily Pretreated CLL – Medscape
13. June 2011
|
High-Dose Melphalan Preferable in Multiple Myeloma
Medscape In fact, in our study, progression-free survival was superior in patients who received high-dose melphalan plus ASCT," Dr. Palumbo told Medscape Medical News. All 402 of the patients in the study received induction therapy consisting of four 28-day … |
See the rest here:
High-Dose Melphalan Preferable in Multiple Myeloma – Medscape
27. June 2011
0 Comments